E-cadherin molecular expresion in the diffuse and intestinal types of gastric adenocarcinoma: A report from Lima, Peru;E-cadherina: Expresión molecular en carcinomas de estómago de tipo difuso y tipo intestinal. Estudio realizado en Lima, Perú

Revista Espanola de Enfermedades Digestivas

Volumn 99, Issue 6, 2007, Pages 325-329

  Arévalo, Fernando ^a   Monge, E ^a   Morales, D ^a  

^a UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

Author keywords

E cadherine; Gastric adenocarcinoma; Gastric signet ring cell carcinoma

Indexed keywords

UVOMORULIN; CADHERIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL ADHESION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; CHEMISTRY; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; ADENOCARCINOMA, PAPILLARY; AGED; CADHERINS; CARCINOMA, SIGNET RING CELL; CELL ADHESION; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 35848933006     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lauren P. The two histological main types of gastric carcinoma. Diffuse and so-called Intestinal type carcinoma: an attempt at histoclinical classification. Acta Patho Microbiol Scand 1965; 64: 31-49.
2. th ed. St. Louis: Mosby; 2004.
3. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333: 32-41.
4. Mecklin JP, Nordling S, Saario J. Carcinoma of the stomach and its heredity in young patients. Scand J Gastroenterol 1988; 23: 307-11.
5. Lauren PA, Nevalainen JT. Epidemiology of intestinal and diffuse types of gastric carcinoma: a time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer 1993; 71: 2926-33.
6. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83: 640-3.
7. Wright P, Williams G. Molecular biology and gastric carcinoma. Gut 1993; 34: 145-7.
8. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda EH, Siewert JR, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-52.
9. Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumours. Pathology and Genetics of tumours of the Digestive System. Lyon: IARC Press; 2000.
10. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Nat Cell Biol 2000; 2: 84-9.
11. Humphries MJ, Newham P. The structure of cell-adhesion molecules. Trends Cell Biol 1998; 8: 78-83.
12. Kim HC, Kim HJ, Kim JC. Reduced E-cadherin expression as a cause of distinctive signet-ring cell variant in colorectal carcinoma. J Korean Med Sci 2002; 17: 23-8.
13. Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol 2004; 121: 884-92.
14. Zhang HK, Zhang QM, Zhao TH, Li YY, Yi YF. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. World J Gastroenterol 2004; 10: 3044-7.
15. Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY, Lai KH, et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett 2003; 201: 97-106.
16. Yong-Ning Z, Cai-Pu X, Biao H, Min L, Liang Q, Dian-Chun F, et al. Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8: 987-93.
17. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402-5.
18. Gayther SA, Goringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998; 58: 4086-9.
19. Ramos de la Medina A, More H, Medina-Franco H, Humar B, Gamboa A, Ortiz LJ, et al. Single nucleotide polymorphisms (SNPs) at CDH1 promoter region in familial gastric cancer. Rev Esp Enferm Dig 2006; 98: 36-41.
20. Grötzinger C, Kneifel J, Patschan D, Schnoy N, Anagnostopoulos I, Faiss S, et al. LI-cadherin: a marker of gastric metaplasia and neoplasia Gut 2001; 49: 73-81.
21. Guzmán G, Pablo, Araya O, Juan, Villaseca H, Miguel, et al. Expresión inmunohistoquímica del complejo E-caderina-catenina en cáncer gástrico: Relación con variables clínico-morfológicas y sobrevida de pacientes. Rev Med Chile 2006; 134: 1002-9.
22. Becker KF, Kremmer E, Eulitz M, Becker I, Handschuh G, Schuhmacher C, et al. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. Am J Pathol 1999; 155: 1803-9.
23. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003; 52: 502-6.
24. Leung WK, Man EP, Yu J, Go MY, To KF, Yamaoka Y, et al. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res 2006; 12: 3216-21.